Thyroglobulin antibody resolution after total thyroidectomy for cancer

Area of Science:

• Endocrinology
• Oncology
• Immunology

Background:

• Thyroglobulin antibodies (TgAb) affect thyroglobulin (Tg) measurements, crucial for monitoring differentiated thyroid cancer (DTC) post-surgery.
• Approximately 10%-25% of DTC patients develop TgAb, potentially complicating cancer surveillance.

Purpose of the Study:

• To investigate the resolution time course of TgAb in DTC patients after thyroidectomy.
• To determine the clinical significance of persistent TgAb elevation on disease recurrence.

Main Methods:

• Retrospective review of 247 DTC patients with preoperative TgAb measurements undergoing thyroidectomy.
• Analysis of TgAb status, resolution time, and association with recurrence using survival and regression analysis.

Main Results:

• 14% of patients were TgAb-positive preoperatively. Median TgAb resolution time was 11 months, with an average decline of 11% IU/mL per month.
• Disease-free survival did not differ significantly between TgAb-positive and TgAb-negative groups.
• In 9 of 34 TgAb-positive patients, antibodies persisted without evidence of recurrent disease.

Conclusions:

• TgAb are common in DTC but generally resolve post-thyroidectomy.
• Persistently elevated TgAb levels after surgery were not associated with an increased risk of recurrence in this patient cohort.